The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $53.30

Today's change+1.74 +3.37%
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $53.30

Today's change+1.74 +3.37%
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.

Community Health Systems Inc Hits New 20-day High

Community Health Systems Inc closed up sharply Wednesday, rallying (U.S.)$1.74 or 3.37% to (U.S.)$53.30 and setting a new 20-day high. Over the last five days, shares have gained 5.00% and 35.73% year to date. Shares have outperformed the S&P 500 by 27.54% during the last year.

Key company metrics

  • Open(U.S.) $51.72
  • Previous close(U.S.) $51.56
  • High(U.S.) $53.51
  • Low(U.S.) $51.54
  • Bid / Ask(U.S.) $51.12 / (U.S.) $54.17
  • YTD % change+35.73%
  • Volume1,980,585
  • Average volume (10-day)1,611,968
  • Average volume (1-month)1,622,137
  • Average volume (3-month)1,820,344
  • 52-week range(U.S.) $34.55 to (U.S.) $57.72
  • Beta1.52
  • Trailing P/E139.46×
  • P/E 1 year forward16.08×
  • Forward PEG0.87×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.38
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.84%

Based on its net profit margin of 0.84%, Community Health Systems Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.54%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,7954,7794,1953,231
Total other revenue--------
Total revenue4,7954,7794,1953,231
Gross profit4,0624,0413,5602,719
Total cost of revenue733738635512
Total operating expense4,4244,4284,1173,016
Selling / general / administrative3,4223,4593,1262,336
Research & development--------
Depreciation / amortization280315299200
Interest expense (income), net operating--------
Unusual expense (income)7709724
Other operating expenses, total-88-84-40-56
Operating income37135178215
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax133107-13572
Income after tax9375-7852
Income tax, total4032-5720
Net income6242-11228
Total adjustments to net income--------
Net income before extra. items6147-9228
Minority interest-32-28-14-24
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6147-9228
Inc. avail. to common incl. extra. items6242-11228
Diluted net income6242-11228
Dilution adjustment0--0--
Diluted weighted average shares11411310795
Diluted EPS excluding extraordinary itemsvalue per share0.530.41-0.860.30
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.000.41-0.270.48